Who Should Attend?
A growing need to merge the clinical and commercial sides of pharma has set the precedent for this event. It will be a must attend meeting for those associated with:
- Clinical Development
- Clinical Discovery
- Drug Development
- Drug Discovery
- Strategic Marketing
- Portfolio Management
- Market Access
- Pricing
- Reimbursement
- Safety
- Risk Management
- Regulation
- Institutional Business Management
- Contracting
- Payer Relations
- Health Economics
- Outcomes Research
- Public Affairs
- Government Affairs
- Pharmacoeconomics
- Pharmacovigilance
- Pharmacoepidermiology
- Epidermiology
- Commercialisation
To ensure you are the first to hear updates on the event please 'opt-in' using the link to the right.
Many thanks
|